...
首页> 外文期刊>Vaccine >Antibodies to serotype 9V exhibit novel serogroup cross-reactivity following infant pneumococcal immunization
【24h】

Antibodies to serotype 9V exhibit novel serogroup cross-reactivity following infant pneumococcal immunization

机译:婴儿肺炎球菌免疫后,血清型9V抗体表现出新型血清群交叉反应

获取原文
获取原文并翻译 | 示例
           

摘要

Cross-reactivity within the pneumococcal immune response was examined in this study. Significant cross-reactivity between serotypes 9V, 15B and 19A was identified in infant post-immunization serum that could not be effectively titrated during specific IgG measurements. Pre-absorption using serotype 9V inhibited this cross-reactivity and normalized titratability in the WHO ELISA for serotypes 15B and 19A. However, this did not affect functional avid IgG and was associated with fewer pneumococcal conjugate vaccine (PCV) doses, suggesting that cross-reactive antibodies were of low avidity. The results in this study have important implications for assessment of vaccine immunogenicity.
机译:在这项研究中检查了肺炎球菌免疫反应中的交叉反应性。在婴儿免疫后血清中鉴定出血清型9V,15B和19A之间的显着交叉反应,这些血清在特异性IgG测量期间无法有效滴定。在15W和19A型血清的WHO ELISA中,使用9V型血清的预吸收抑制了这种交叉反应性和标准化的滴定度。但是,这不会影响功能性抗体IgG,并且与较少的肺炎球菌结合疫苗(PCV)剂量相关,这表明交叉反应抗体的亲和力较低。这项研究的结果对评估疫苗的免疫原性具有重要意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号